v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating activities:    
Net loss $ (21,033) $ (13,485)
Adjustments to reconcile net loss to net cash provided by operating activities:    
Depreciation 11,749 11,674
Non-cash loss on extinguishment of debt 3,477 0
Non-cash operating lease expense 2,249 2,500
Amortization expense of finance leases 1,838 1,857
Amortization of intangible assets 1,264 1,264
Stock-based compensation expense 736 2,486
Gain on divestiture of business (1,178) 0
Deferred tax (benefit) provision (1,208) 538
Unrealized foreign currency gain (2,272) 0
Other 1,142 1,311
Changes in operating assets and liabilities:    
Accounts receivable 12,314 11,255
Prepaid expenses and other assets (123) (1,077)
Accounts payable, accrued expenses and other liabilities 3,316 515
Contract liabilities and customer advances 70 (4,460)
Operating lease liabilities (4,300) (4,384)
Net cash provided by operating activities 8,041 9,994
Investing activities:    
Proceeds from divestiture of business, net of cash transferred 55,740 0
Purchases of property and equipment (608) (524)
Capitalized internal-use software costs (11,674) (10,868)
Net cash provided by (used in) investing activities 43,458 (11,392)
Financing activities:    
Principal payments of term loan (44,550) (225)
Principal payments on finance leases (1,977) (1,609)
Principal payments on insurance financing (1,293) (1,321)
Payment of preferred stock and common stock issuance costs (1,219) 0
Contingent consideration payment at initial value 0 (859)
Payment of financing and debt issuance costs 0 (559)
Other (501) (3)
Net cash used in financing activities (49,540) (4,576)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (12) 2,032
Net increase (decrease) in cash, cash equivalents and restricted cash 1,947 (3,942)
Cash, cash equivalents and restricted cash at beginning of period 26,800 33,468
Cash, cash equivalents and restricted cash at end of period 28,747 29,526
Cash and cash equivalents 25,707 25,993
Restricted cash 3,040 3,533
Total cash, cash equivalents and restricted cash 28,747 29,526
Supplemental cash flow disclosure:    
Interest paid 2,146 2,658
Supplemental disclosures of non-cash investing and financing activities:    
Divestiture escrow receivables and post-close adjustment receivable 4,844 0
Settlement of restricted stock unit liability 1,586 314
Modification of operating right-of-use assets 1,136 0
Change in accounts payable and accrued expenses related to capital expenditures 793 898
Series B convertible redeemable preferred stock dividends accrued but not yet paid (related parties) 0 8,933
Right-of-use assets obtained in exchange for finance lease liabilities $ 0 $ 619